![]() ![]() He has also held executive positions at Quintiles Transnational (now IQVIA, Inc), and Pharmaco LSR (now PPD, Inc). Bilawsky built several leading contract research companies serving as Chief Executive Officer of Precision Health Economics, the i3 Global division of UnitedHealth Group, and INC Research. Bilawsky has over four decades of pharmaceutical and healthcare industry experience, dominantly in the global contract research industry. Glenn Bilawsky is the current CEO of Discovery Life Sciences ( ), a private equity-invested global life science research services corporation specializing in biomarker research and development services. John has been listed among the PharmaVoice 100 most inspirational leaders in the health and science industry. He also worked with Sterling Drug earlier in his career. ![]() He played a pivotal role in growing Pharmaco and during his tenure, Pharmaco became the second largest CRO in the industry at that time. Previously, John served as President and Chief Operating Officer at Pharmaco (currently PPD). Prior to founding ResearchPoint Global, John served as Executive Vice President of Quintiles Transnational Corporation (currently IQVIA), where he provided key leadership in acquisitions and integrations, helping Quintiles to become the CRO industry’s market leader. He founded ResearchPoint Global which was acquired by WuXi AppTec in 2017. John’s respected career spans more than four decades and has included senior leadership roles in the global biopharmaceutical service industry. The new advisory board that will support Benchmark in upcoming ventures this year is made up of a talented team of masterful industry experts including John Farinacci, Glenn Bilawsky, and Karen Skelton. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |